Discover the latest breakthroughs in oncology, including pivotal FDA decisions, promising therapies, and new treatment ...

Jacob E. Berchuck, MD, highlights novel findings pointing to androgen receptor signaling and Wnt pathway activation as key correlates of poor response to therapy.